Synta Pharmaceuticals Corp. Company Information
Employees at Synta Pharmaceuticals Corp.
Showing 15 of 306| JOB TITLE | WORK EMAIL | WORK PHONE | LOCATION | |
|---|---|---|---|---|
| Director Cancer Biology and In Vivo Pharmacology | ||||
| Senior Director Chemical Development A | Bedford, Massachusetts | |||
| Manager | ||||
| Senior Desktop Support Technician | Gonzalez, Florida | |||
| Clinical Research Specialist | Cambridge, Massachusetts | |||
| Clinical Research Associate | Boston, Massachusetts | |||
| Senior Clinical Trial Manager | Boston, Massachusetts | |||
| Investor Relations Manager | Boston, Massachusetts | |||
| Administrative Assistant | Boston, Massachusetts | |||
| Senior Clinical Research Associate | Boston, Massachusetts | |||
| Senior Programmer Analyst | Lexington, Massachusetts | |||
| Employee | ||||
| Employee | Boston, Massachusetts | |||
| Associate Director | Pa Nesar, Mazandaran | |||
| Qc Scientist | Boston, Massachusetts |
Director Cancer Biology and In Vivo Pharmacology
Senior Director Chemical Development A
Bedford, Massachusetts Manager
Senior Desktop Support Technician
Gonzalez, Florida Clinical Research Specialist
Cambridge, Massachusetts Clinical Research Associate
Boston, Massachusetts Senior Clinical Trial Manager
Boston, Massachusetts Investor Relations Manager
Boston, Massachusetts Administrative Assistant
Boston, Massachusetts Senior Clinical Research Associate
Boston, Massachusetts Senior Programmer Analyst
Lexington, Massachusetts Employee
Employee
Boston, Massachusetts Associate Director
Pa Nesar, Mazandaran Qc Scientist
Boston, Massachusetts Enter an employee name to search and verify work emails, phone numbers and social links etc.
Synta Pharmaceuticals Corp.'s Email Format
We found 7 email formats used by Synta Pharmaceuticals Corp. employees. The most common Synta Pharmaceuticals Corp. email format is first_initial last ex.(jdoe@syntapharma.com) being used 68% of the time.
first_initial last
68%
last
13%
first_initial.last
7%
others
5%
first
4%
first.last
1%
first last
1%